BETA-CAROTENE INHIBITS THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN

被引:208
|
作者
JIALAL, I
NORKUS, EP
CRISTOL, L
GRUNDY, SM
机构
[1] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235
[2] UNIV TEXAS,SW MED CTR,DEPT CLIN NUTR,DALLAS,TX 75235
[3] NEW YORK MED COLL,BRONX,NY
[4] OUR LADY MERCY MED CTR,BRONX,NY
关键词
ANTIOXIDANT; LIPOPROTEIN; BETA-CAROTENE; ATHEROSCLEROSIS; (HUMAN MACROPHAGE);
D O I
10.1016/0005-2760(91)90164-D
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several lines of evidence indicate that oxidized LDL (Ox-LDL) may promote atherogenesis. Hence, the role of antioxidants in the prevention of LDL oxidation needs to be determined. Beta-Carotene, in addition to being an efficient quencher of singlet oxygen, can also function as a radical-trapping antioxidant. Since previous studies have failed to show that beta-carotene inhibits LDL oxidation, we re-examined its effect on the oxidative modification of LDL. For these studies, LDL was oxidized in both a cell-free (2.5-mu-M Cu2+ in PBS) and a cellular system (human monocyte macrophages in Ham's F-10 medium). Beta-Carotene inhibited the oxidative modification of LDL in both systems as evidenced by a decrease in the lipid peroxide content (thiobarbituric-acid-reacting substances activity), the negative charge of LDL (electrophoretic mobility) and the formation of conjugated dienes. By inhibiting LDL oxidation, beta-carotene substantially decreased its degradation by macrophages. Beta-Carotene (2-mu-M) was more potent than alpha-tocopherol (40-mu-M) in inhibiting LDL oxidation. Thus, beta-carotene, like ascorbate and alpha-tocopherol, inhibits LDL oxidation and might have an important role in the prevention of atherosclerosis.
引用
下载
收藏
页码:134 / 138
页数:5
相关论文
共 50 条
  • [31] PHYSIOLOGICAL LEVELS OF ASCORBATE INHIBIT THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    JIALAL, I
    VEGA, GL
    GRUNDY, SM
    ATHEROSCLEROSIS, 1990, 82 (03) : 185 - 191
  • [32] OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN AS AN INITIATING FACTOR IN ATHEROGENESIS - AN HYPOTHESIS
    STEINBERG, D
    PARTHASARATHY, S
    WITZTUM, JL
    QUINN, MT
    FONG, LG
    CLINICAL RESEARCH, 1987, 35 (03): : A659 - A659
  • [33] PROTECTION AGAINST OXIDATIVE MODIFICATION OF HUMAN LOW-DENSITY-LIPOPROTEIN BY CIMETIDINE
    CHANCE, D
    CHEN, C
    LOO, G
    FASEB JOURNAL, 1994, 8 (04): : A449 - A449
  • [34] THE PLASMA PAF ACETYLHYDROLASE PREVENTS OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    STAFFORINI, DM
    ZIMMERMAN, GA
    MCINTYRE, TM
    PRESCOTT, SM
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 10 (1-2): : 53 - 56
  • [35] ACTIVATION OF 15-LIPOXYGENASE BY LOW-DENSITY-LIPOPROTEIN IN VASCULAR ENDOTHELIAL-CELLS - RELATIONSHIP TO THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
    DERIAN, CK
    LEWIS, DF
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1992, 45 (01): : 49 - 57
  • [36] PROTECTION OF LOW-DENSITY-LIPOPROTEIN AGAINST OXIDATIVE MODIFICATION BY HIGH-DENSITY-LIPOPROTEIN ASSOCIATED PARAOXONASE
    MACKNESS, MI
    ARROL, S
    ABBOTT, C
    DURRINGTON, PN
    ATHEROSCLEROSIS, 1993, 104 (1-2) : 129 - 135
  • [37] Melatonin inhibits oxidative modification of low density lipoprotein.
    Kelly, MR
    McCauley, L
    Chen, C
    Loo, G
    FASEB JOURNAL, 1996, 10 (03): : 1149 - 1149
  • [38] INHIBITORY EFFECT OF HIGH-DENSITY-LIPOPROTEIN (HDL) ON OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN (LDL)
    PARTHASARATHY, S
    FONG, LG
    STEINBERG, D
    CIRCULATION, 1987, 76 (04) : 479 - 479
  • [39] AMINOGUANIDINE INHIBITS OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN PROTEIN AND THE SUBSEQUENT INCREASE IN UPTAKE BY MACROPHAGE SCAVENGER RECEPTORS
    PICARD, S
    PARTHASARATHY, S
    FRUEBIS, J
    WITZTUM, JL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) : 6876 - 6880
  • [40] ESTRADIOL INHIBITS LOW-DENSITY-LIPOPROTEIN OXIDATION
    RIFICI, VA
    KHACHADURIAN, AK
    CLINICAL RESEARCH, 1993, 41 (03): : A599 - A599